MicroTech Medical (Hangzhou) Co., Ltd. (HKG:2235)

Hong Kong · Delayed Price · Currency is HKD

6.65

-0.05 (-0.75%)

Nov 13, 2026, 3:53 PM HKT

Market Cap	2.76B -1.7%
Revenue (ttm)	957.05M +88.1%
Net Income	95.50M
EPS	0.24
Shares Out	415.08M
PE Ratio	27.47
Forward PE	19.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,500
Open	6.65
Previous Close	6.70
Day's Range	6.61 - 6.65
52-Week Range	5.70 - 8.28
Beta	0.48
Analysts	Buy
Price Target	10.56 (+58.8%)
Est. Earnings	Nov 20, 2026

About HKG:2235

MicroTech Medical (Hangzhou) Co., Ltd. provides diabetes management, diabetes treatment, and diabetes monitoring and treatment medical devices in China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; API open platform; and diabetes digital management software. It also involved in scientific resea... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2011

Employees 702

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 2235

Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 2235 stock is "Buy." The 12-month stock price target is $10.56, which is an increase of 58.80% from the latest price.

Price Target

$10.56

(58.80% upside)

Analyst Consensus: Buy

Stock Forecasts